Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Washington, D.C., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Foundation for Financial Planning (FFP) announced today that Charles Schwab Foundation will serve as the Presenting Sponsor of its Power of Pro...
-
FORESIGHT ENTERPRISE VCT PLCLEI: 213800MWJNR3WZZ3ZP42 UNAUDITED HALF-YEARLY FINANCIAL REPORTFOR THE PERIOD ENDED 30 JUNE 2024 Financial Highlights Total net assets £171.1 millionA special dividend...
-
The intended selling valuation represents an increase of 47% from the valuation at the time of SciSparc’s initial investment in MitoCareX Bio TEL AVIV, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- ...
-
Pune, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Supply Chain Management Market Size Analysis: “The SNS Insider report indicates that the Supply Chain Management Market was valued at USD 26.2 billion in...
-
Restructuring benefits financial position and reduces debt under the notes by approximately 9.5% Reaffirms target of $100 million annualized revenue exit run rate for 2024, with...
-
SAN FRANCISCO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Ibotta, Inc. (NYSE: IBTA) investors who suffered substantial losses to submit your losses now. The firm also encourages persons...
-
SAN FRANCISCO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges iLearningEngines, Inc. (NASDAQ: AILE) investors who suffered substantial losses to submit your losses now. The firm also...
-
Los Angeles, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Nearly two-thirds (63 percent) of public high school counselors who participated in a new survey say that fewer of their students plan to...
-
HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...
-
September 26, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2024 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an...